Prelude Capital Management, LLC Incyte Corp Transaction History

Prelude Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$52.16 - $64.19 $245,204 - $301,757	4,701 New	4,701 $295,000
Q3 2022 Nov 14, 2022	BUY	$66.18 - $82.86 $570,273 - $714,004	8,617 New	8,617 $574,000
Q4 2021 Feb 14, 2022	SELL	$63.34 - $74.11 $212,189 - $248,268	-3,350 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$68.67 - $84.02 $82,060 - $100,403	-1,195 Reduced 26.29%	3,350 $230,000
Q2 2021 Aug 16, 2021	SELL	$79.87 - $87.53 $290,487 - $318,346	-3,637 Reduced 44.45%	4,545 $382,000
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $317,155 - $419,286	4,172 Added 104.04%	8,182 $665,000
Q4 2020 Feb 16, 2021	BUY	$80.74 - $97.7 $122,644 - $148,406	1,519 Added 60.98%	4,010 $349,000
Q3 2020 Nov 16, 2020	BUY	$85.07 - $109.69 $211,909 - $273,237	2,491 New	2,491 $224,000
Q2 2020 Aug 14, 2020	SELL	$74.18 - $108.93 $37,535 - $55,118	-506 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$63.18 - $85.97 $113,597 - $154,574	-1,798 Reduced 78.04%	506 $37,000
Q4 2019 Feb 14, 2020	BUY	$73.04 - $95.72 $140,748 - $184,452	1,927 Added 511.14%	2,304 $201,000
Q3 2019 Nov 14, 2019	SELL	$72.82 - $86.52 $546,878 - $649,765	-7,510 Reduced 95.22%	377 $28,000
Q1 2019 May 15, 2019	BUY	$63.56 - $88.17 $129,153 - $179,161	2,032 Added 34.71%	7,887 $678,000
Q4 2018 Feb 14, 2019	SELL	$58.5 - $69.94 $799,402 - $955,730	-13,665 Reduced 70.01%	5,855 $372,000
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $1.21 Million - $1.45 Million	19,520 New	19,520 $1.35 Million

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.